This is a real world study of Gallbladder disorder among people who take Reclast, Glucosamine and MSM. The study is created by eHealthMe based on reports from FDA and social media.
What are the drugs
Reclast (latest outcomes from 8,614 users) has active ingredients of zoledronic acid. It is often used in osteoporosis.
Glucosamine and msm (latest outcomes from 27 users) has active ingredients of glucosamine; methylsulfonylmethane. It is often used in arthritis.
On Dec, 13, 2014: 28 people reported to have side effects when taking Reclast, Glucosamine and MSM. Among them, 1 people (3.57%) has Gallbladder Disorder.
Gender of people who have Gallbladder disorder when taking the drugs * :
|Gallbladder disorder||100%||0% |
Age of people who have Gallbladder disorder when taking the drugs * :
|Gallbladder disorder||0%||0%||0%||0%||0%||0%||0%||100% |
Severity of Gallbladder disorder when taking the drugs ** :
How people recovered from Gallbladder disorder ** :
* Approximation only. Some reports may have incomplete information.
** Reports from social media are used.
More about the drug combination: Reclast, Glucosamine and MSM drug interactions
You can also:
NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.